Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arcadia BiosciencesRKDA -18.59%43 PB Ratio is 0.40 as of Aug. 13, 2026, which is 66% below its 10-year median of 1.18. GuruFocus rates RKDA with a GF Score™ of 43/100 and a GF Value™ of $2.84 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 1,900 Consumer Packaged Goods companies, Arcadia Biosciences ranks better than 88.05% on this metric.
The historical rank and industry rank for Arcadia Biosciences's PB Ratio or its related term are showing as below:
RKDA'
s PB Ratio Range Over the Past 10 Years
Min: 0.17 Med: 1.18 Max: 98.35
Current: 0.41
During the past 13 years, Arcadia Biosciences's highest PB Ratio was 98.35. The lowest was 0.17. And the median was 1.18.
RKDA's PB Ratio is ranked better than 88.05% of 1900
companies
in the Consumer Packaged Goods industry
Industry Median: 1.4
vs RKDA: 0.41
During the past 12 months, Arcadia Biosciences's average Book Value Per Share Growth Rate was -78.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -55.50% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was -51.50% per year.
During the past 10 years, the average Book Value Per Share Growth Rate was -39.50% per year.
During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Arcadia Biosciences was -1.40% per year. The lowest was -56.70% per year. And the median was -48.85% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Arcadia Biosciences PB Ratio Related Terms
Arcadia Biosciences PB Ratio Historical Data
* Premium members only.
The historical data trend for Arcadia Biosciences's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Packaged Foods subindustry, Arcadia Biosciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arcadia Biosciences PB Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Arcadia Biosciences's PB Ratio distribution charts can be found below:
* The bar in red indicates where Arcadia Biosciences's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Arcadia Biosciences (RKDA) has a PB Ratio of 0.40 as of Aug. 13, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Arcadia Biosciences and its competitors. This is 66% below median its historical median of 1.18. Over the past decade, Arcadia Biosciences' PB Ratio has ranged from 0.17 to 98.35. According to the industry distribution chart, Arcadia Biosciences ranks #227 out of 1900 companies in the Consumer Packaged Goods industry, placing it in the top 11.9%.
Is Arcadia Biosciences' PB Ratio too high?
Arcadia Biosciences' current PB Ratio of 0.40 is 66% below median its 10-year median of 1.18. Over the past 10 years, this metric has ranged from a low of 0.17 to a high of 98.35. The Consumer Packaged Goods industry median PB Ratio is 1.40. Arcadia Biosciences' value of 0.40 is 71.4% below this industry median. Based on the distribution chart, Arcadia Biosciences ranks #227 out of 1900 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Arcadia Biosciences has a GF Score™ of 43/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arcadia Biosciences' PB Ratio compare to ORISF and ARRT?
According to the Consumer Packaged Goods industry distribution chart, Arcadia Biosciences ranks #227 out of 1900 companies for PB Ratio. This places Arcadia Biosciences in the top 12% of its industry — outperforming the majority of peers. The industry median PB Ratio is 1.40. Arcadia Biosciences' value of 0.40 is 71.4% below this benchmark. Historically, Arcadia Biosciences' own PB Ratio has ranged from 0.17 to 98.35 over the past decade. While the company's 10-year median is 1.18 vs. the industry median of 1.40, Arcadia Biosciences has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Consumer Packaged Goods company?
The median PB Ratio among Consumer Packaged Goods companies is 1.40, based on 1,900 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arcadia Biosciences's current PB Ratio of 0.40 is 71.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Arcadia Biosciences and its competitors. For the Consumer Packaged Goods industry, the median PB Ratio is 1.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arcadia Biosciences's current PB Ratio is 0.40, which is 66% below median its own 10-year median of 1.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arcadia Biosciences stock overvalued right now?
Based on GuruFocus' analysis, Arcadia Biosciences (RKDA) is currently considered Possible Value Trap. The stock's GF Value™ is $2.84, compared to a current price of $0.56 — trading 80.3% below its estimated fair value. The current PB Ratio is 0.40, which is 66% below median its 10-year median of 1.18 and 71.4% below the Consumer Packaged Goods industry median of 1.40. Arcadia Biosciences' overall GF Score™ is 43/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Arcadia Biosciences (RKDA), the current PB Ratio is 0.40 as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arcadia Biosciences (RKDA) Overvalued in 2026?
Based on GuruFocus' analysis, Arcadia Biosciences stock appears to be undervalued.
The current stock price of $0.56 is trading 80.3% below its estimated GF Value™ of $2.84.
GuruFocus considers Arcadia Biosciences to be Possible Value Trap.
Key valuation signals for RKDA:
PB Ratio: 0.40 (66% below median its 10-year median of 1.18)
GF Value™: $2.84 vs. price of $0.56 (80.3% below fair value)
Industry Position: 71.4% below the Consumer Packaged Goods median (#227 of 1900)
No single metric tells the full story. See the RKDA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arcadia Biosciences Inc is a company with science-based approaches to develop high value products and drive innovation in the consumer goods industry. The company has one operating and reportable segment, which derives revenue from the sale of Zola coconut water. The company's consumer brands in the food, beverage, and body care categories, and others. Its products include: Zola Coconut Water, and Agronomic Wheat Traits. Geographically, the company operates in United States, Argentina, India, and Canada. It derives maximum revenue from United States.
43GF Score
Get the complete analysis for RKDA
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RKDA has been successfully added to your 
